Please login to the form below

Not currently logged in
Email:
Password:

PPMS

This page shows the latest PPMS news and features for those working in and with pharma, biotech and healthcare.

Roche and NHS England hail pricing deal on MS drug Ocrevus

Roche and NHS England hail pricing deal on MS drug Ocrevus

The agreement means NICE can now reverse the rejection it announced in November, and Ocrevus(ocrelizumab), will be fully available to patients with primary progressive multiple sclerosis (PPMS) in England, the ... England's contribution to its revenues

Latest news

More from news
Approximately 2 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • It's time to change the conversation

    Take Multiple Sclerosis (MS) for example. MS has four different disease manifestations: Relapsing Remitting (RRMS), Secondary Progressive (SPMS), Primary Progressive (PPMS) and Progressive Relapsing (PRMS).

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics